US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CITIUS ONCOLOGY INC

1.10

-0.0150-1.35%

Volume:40.82K

Turnover:44.95K

Market Cap:96.66M

PE:-3.58

High:1.12

Open:1.11

Low:1.09

Close:1.11

52wk High:6.19

52wk Low:0.5506

Shares:88.28M

Float Shares:12.32M

Volume Ratio:1.35

T/O Rate:0.33%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3060

EPS(LYR):-0.3380

ROE:-47.41%

ROA:-13.96%

PB:1.65

PE(LYR):-3.24

Loading ...

Overview Company News Filings

Citius Oncology Showcases LYMPHIR at American Society of Hematology Annual Meeting

Citius Oncology to advance launch of Lymphir with Verix AI integration

Citius Oncology Signs US Distribution Deal With McKesson for Lymphir

MT Newswires Live

BRIEF-Citius Oncology Signs U.S. Distribution Agreement With Mckesson To Support Lymphir Commercial Launch

Citius Oncology announces distribution agreement with McKesson

Citius Oncology Says Commercialization Deal Signed With Eversana for Planned Launch of Lymphir in Q4

MT Newswires Live

BRIEF-Citius Oncology Signs Exclusive Commercialization Agreement With EVERSANA To Support Planned Q4 2025 Launch Of LYMPHIR

Citius Oncology Inc: Co Plans to Commercially Launch Lymphir in United States in Q4 2025

THOMSON REUTERS

Citius Oncology Signs Exclusive Commercialization Agreement With Eversana to Support Planned Q4 2025 Launch of Lymphir™

THOMSON REUTERS

Citius Sets Up Access to Lymphir in Southern Europe

MT Newswires Live

BRIEF-Citius Oncology Enters Exclusive Distribution Agreement With Integris Pharma S.A.

Citius Oncology Inc - Enters Exclusive Distribution Agreement With Integris Pharma S.a.

THOMSON REUTERS

Citius Oncology Raised to Buy From Hold by Maxim Group

Citius Oncology upgraded to Buy from Hold at Maxim

Citius Oncology Inc : Maxim Group Raises to Buy From Hold

THOMSON REUTERS

BRIEF-Citius Oncology Announces Closing Of $9 Million Registered Direct Offering And Concurrent Private Placement

Citius Oncology Prices $9 Million Securities Offering, Concurrent Private Placement

MT Newswires Live

BRIEF-Citius Oncology Prices $9M Direct Offering & Private Placement

Citius Oncology Inc - Offering Price for Share and Warrant Is $1.75

THOMSON REUTERS

Press Release: Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CTOR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"CTOR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTOR\",,,,,undefined,":{"symbol":"CTOR","market":"US","secType":"STK","nameCN":"CITIUS ONCOLOGY INC","latestPrice":1.095,"timestamp":1772035586054,"preClose":1.11,"halted":0,"volume":40816,"delay":0,"changeRate":-0.013513513513513624,"floatShares":12321000,"shares":88275200,"eps":-0.305988,"marketStatus":"Trading","change":-0.015,"latestTime":"02-25 11:10:39 EST","open":1.11,"high":1.12,"low":1.09,"amount":44945.313904,"amplitude":0.027027,"askPrice":1.1,"askSize":100,"bidPrice":1.09,"bidSize":900,"shortable":3,"etf":0,"ttmEps":-0.305988,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1772053200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.11,"preHourTrading":{"tag":"盘前","latestPrice":1.12,"preClose":1.11,"latestTime":"08:22 EST","volume":50,"amount":56.00000000000001,"timestamp":1772025756019,"change":0.01,"changeRate":0.009009,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.11,"preClose":1.11,"latestTime":"19:03 EST","volume":1053,"amount":1176.285,"timestamp":1771977782189,"change":0,"changeRate":0,"amplitude":0.036036},"volumeRatio":1.346545},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTOR\",,,,,undefined,":{"symbol":"CTOR","floatShares":12321000,"roa":"-13.96%","roe":"-47.41%","lyrEps":-0.337956,"volumeRatio":1.346545,"shares":88275200,"dividePrice":0,"high":1.12,"amplitude":0.027027,"preClose":1.11,"low":1.09,"week52Low":0.5506,"pbRate":"1.65","psRate":"24.51","week52High":6.19,"institutionHeld":0,"latestPrice":1.095,"committee":0.8,"eps":-0.305988,"divideRate":0,"volume":40816,"delay":0,"ttmEps":-0.305988,"open":1.11,"prevYearClose":1,"prevWeekClose":1.16,"prevMonthClose":1.06,"prevQuarterClose":1,"fiveDayClose":1.17,"twentyDayClose":1.1,"sixtyDayClose":1.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTOR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-13","symbol":"CTOR","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1770958800000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2025-12-23","symbol":"CTOR","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1766466000000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2025-08-12","symbol":"CTOR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTOR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTOR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1758862800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTOR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTOR","date":"2026-02-24","current":-3.578572,"percent":0.465608,"low":-14.569058,"twenty":-5.671547,"median":-4.099793,"eighty":-3.424867,"high":-1.770477,"avg":-4.52826,"sd":1.880201,"marketCap":100633732},"quantilePoints":[{"date":"2024-08-23","current":-7.506449,"twenty":-8.175502,"median":-7.996,"eighty":-7.800179,"marketCap":131199450},{"date":"2024-08-30","current":-6.464428,"twenty":-8.028637,"median":-7.567643,"eighty":-6.639734,"marketCap":126208166},{"date":"2024-09-06","current":-6.847911,"twenty":-7.922567,"median":-7.149219,"eighty":-6.405992,"marketCap":133695091},{"date":"2024-09-13","current":-5.989639,"twenty":-7.726747,"median":-6.50095,"eighty":-6.274513,"marketCap":116938640},{"date":"2024-09-20","current":-6.099206,"twenty":-7.555404,"median":-6.464428,"eighty":-5.97503,"marketCap":119077761},{"date":"2024-09-27","current":-5.222673,"twenty":-7.472896,"median":-6.354861,"eighty":-5.953117,"marketCap":101964790},{"date":"2024-10-04","current":-4.309619,"twenty":-7.088957,"median":-6.190511,"eighty":-5.617113,"marketCap":84138777},{"date":"2024-10-11","current":-3.542653,"twenty":-6.749301,"median":-6.099206,"eighty":-5.018149,"marketCap":69164927},{"date":"2024-10-18","current":-3.944397,"twenty":-6.661648,"median":-5.953117,"eighty":-4.16353,"marketCap":77008372},{"date":"2024-10-25","current":-4.399098,"twenty":-6.559386,"median":-5.916595,"eighty":-4.331532,"marketCap":85885727},{"date":"2024-10-31","current":-4.419185,"twenty":-6.486341,"median":-5.66094,"eighty":-4.324228,"marketCap":86277899},{"date":"2024-11-08","current":-4.602892,"twenty":-6.464428,"median":-5.16789,"eighty":-4.287705,"marketCap":89864492},{"date":"2024-11-15","current":-3.904222,"twenty":-6.464428,"median":-4.930496,"eighty":-4.287705,"marketCap":76224028},{"date":"2024-11-22","current":-3.564201,"twenty":-6.420601,"median":-4.784407,"eighty":-3.944397,"marketCap":69585621},{"date":"2024-11-29","current":-3.356755,"twenty":-6.347557,"median":-4.693102,"eighty":-3.842134,"marketCap":65535551},{"date":"2024-12-06","current":-5.916595,"twenty":-6.296426,"median":-4.747885,"eighty":-3.776395,"marketCap":115512559},{"date":"2024-12-13","current":-3.907874,"twenty":-6.201468,"median":-4.620605,"eighty":-3.842134,"marketCap":76295332},{"date":"2024-12-20","current":-3.871352,"twenty":-6.164946,"median":-4.528752,"eighty":-3.842134,"marketCap":75582291},{"date":"2024-12-27","current":-3.50613,"twenty":-6.135728,"median":-4.435255,"eighty":-3.725263,"marketCap":68451887},{"date":"2025-01-03","current":-4.012144,"twenty":-6.10651,"median":-4.399098,"eighty":-3.717959,"marketCap":84851818},{"date":"2025-01-10","current":-3.992285,"twenty":-6.033466,"median":-4.399098,"eighty":-3.747177,"marketCap":84431834},{"date":"2025-01-17","current":-4.465946,"twenty":-5.967726,"median":-4.376046,"eighty":-3.723807,"marketCap":94449170},{"date":"2025-01-24","current":-4.296782,"twenty":-5.953117,"median":-4.35308,"eighty":-3.739872,"marketCap":90871550},{"date":"2025-01-31","current":-4.262949,"twenty":-5.953117,"median":-4.346141,"eighty":-3.761786,"marketCap":90156026},{"date":"2025-02-07","current":-4.026118,"twenty":-5.938508,"median":-4.309619,"eighty":-3.767526,"marketCap":85147358},{"date":"2025-02-14","current":-4.330615,"twenty":-5.916595,"median":-4.296782,"eighty":-3.799613,"marketCap":91587074},{"date":"2025-02-21","current":-3.72014,"twenty":-5.901986,"median":-4.296782,"eighty":-3.761786,"marketCap":85862882},{"date":"2025-02-28","current":-3.689139,"twenty":-5.807029,"median":-4.262949,"eighty":-3.720436,"marketCap":85147358},{"date":"2025-03-07","current":-3.162119,"twenty":-5.639027,"median":-4.229116,"eighty":-3.689139,"marketCap":72983450},{"date":"2025-03-14","current":-2.294087,"twenty":-5.507546,"median":-4.152992,"eighty":-3.653403,"marketCap":52948777},{"date":"2025-03-21","current":-1.891071,"twenty":-5.317631,"median":-4.127617,"eighty":-3.617985,"marketCap":43646965},{"date":"2025-03-28","current":-2.030577,"twenty":-5.251891,"median":-4.059951,"eighty":-3.565808,"marketCap":46866823},{"date":"2025-04-04","current":-2.191783,"twenty":-5.220193,"median":-4.053963,"eighty":-3.506186,"marketCap":50587548},{"date":"2025-04-11","current":-1.919282,"twenty":-5.198143,"median":-4.02178,"eighty":-3.38992,"marketCap":44298092},{"date":"2025-04-17","current":-2.002676,"twenty":-5.149629,"median":-4.014793,"eighty":-3.224122,"marketCap":46222851},{"date":"2025-04-25","current":-1.987175,"twenty":-5.113107,"median":-3.992285,"eighty":-3.104751,"marketCap":45865089},{"date":"2025-05-02","current":-2.759104,"twenty":-5.076585,"median":-3.944397,"eighty":-2.759104,"marketCap":63681637},{"date":"2025-05-09","current":-2.619599,"twenty":-4.930496,"median":-3.907874,"eighty":-2.693382,"marketCap":60461779},{"date":"2025-05-16","current":-2.437632,"twenty":-4.930496,"median":-3.890787,"eighty":-2.691522,"marketCap":63331031},{"date":"2025-05-23","current":-2.506208,"twenty":-4.784407,"median":-3.875146,"eighty":-2.619599,"marketCap":65112685},{"date":"2025-05-30","current":-2.451953,"twenty":-4.784407,"median":-3.871352,"eighty":-2.502848,"marketCap":63703103},{"date":"2025-06-06","current":-2.671453,"twenty":-4.755189,"median":-3.805483,"eighty":-2.487546,"marketCap":69405829},{"date":"2025-06-13","current":-4.04849,"twenty":-4.660231,"median":-3.776135,"eighty":-2.502848,"marketCap":105182030},{"date":"2025-06-20","current":-4.268817,"twenty":-4.617062,"median":-3.83483,"eighty":-2.506208,"marketCap":110906223},{"date":"2025-06-27","current":-9.639263,"twenty":-4.842843,"median":-3.873249,"eighty":-2.506208,"marketCap":250433407},{"date":"2025-07-03","current":-14.569058,"twenty":-5.098498,"median":-3.876214,"eighty":-2.511716,"marketCap":378512206},{"date":"2025-07-11","current":-8.950744,"twenty":-5.244587,"median":-3.890787,"eighty":-2.545647,"marketCap":232545306},{"date":"2025-07-18","current":-4.40652,"twenty":-5.303022,"median":-3.909331,"eighty":-2.598329,"marketCap":114483843},{"date":"2025-07-25","current":-5.370447,"twenty":-5.303022,"median":-3.944397,"eighty":-2.622079,"marketCap":139527183},{"date":"2025-08-01","current":-7.246465,"twenty":-5.617113,"median":-3.968341,"eighty":-2.631999,"marketCap":188267172},{"date":"2025-08-08","current":-6.066045,"twenty":-5.92757,"median":-3.993409,"eighty":-2.65122,"marketCap":157599217},{"date":"2025-08-15","current":-5.071831,"twenty":-5.92757,"median":-4.017441,"eighty":-2.668242,"marketCap":134797404},{"date":"2025-08-22","current":-4.806444,"twenty":-5.916595,"median":-4.026118,"eighty":-2.679481,"marketCap":127744051},{"date":"2025-08-29","current":-6.251327,"twenty":-5.92757,"median":-4.051227,"eighty":-2.692266,"marketCap":166145638},{"date":"2025-09-05","current":-5.514142,"twenty":-5.933303,"median":-4.056957,"eighty":-2.700326,"marketCap":146552992},{"date":"2025-09-12","current":-5.938837,"twenty":-5.933303,"median":-4.063335,"eighty":-2.734303,"marketCap":157840405},{"date":"2025-09-19","current":-5.498923,"twenty":-5.933303,"median":-4.134553,"eighty":-2.759104,"marketCap":146148523},{"date":"2025-09-26","current":-5.71888,"twenty":-5.924891,"median":-4.16145,"eighty":-2.75929,"marketCap":151994464},{"date":"2025-10-03","current":-5.907415,"twenty":-5.938047,"median":-4.221426,"eighty":-2.76177,"marketCap":157005270},{"date":"2025-10-10","current":-5.750303,"twenty":-5.938047,"median":-4.262949,"eighty":-2.769272,"marketCap":152829598},{"date":"2025-10-17","current":-5.624613,"twenty":-5.934887,"median":-4.265883,"eighty":-2.785269,"marketCap":149489061},{"date":"2025-10-24","current":-5.247544,"twenty":-5.933303,"median":-4.296782,"eighty":-2.845783,"marketCap":139467448},{"date":"2025-10-31","current":-5.436079,"twenty":-5.924891,"median":-4.3032,"eighty":-2.870708,"marketCap":144478254},{"date":"2025-11-07","current":-4.524828,"twenty":-5.916595,"median":-4.309619,"eighty":-2.884898,"marketCap":120259356},{"date":"2025-11-14","current":-4.179182,"twenty":-5.914759,"median":-4.309619,"eighty":-2.896465,"marketCap":111072877},{"date":"2025-11-21","current":-3.550733,"twenty":-5.907415,"median":-4.304871,"eighty":-2.952238,"marketCap":94370189},{"date":"2025-11-28","current":-4.304871,"twenty":-5.907415,"median":-4.296782,"eighty":-3.104751,"marketCap":114413415},{"date":"2025-12-05","current":-3.487889,"twenty":-5.875992,"median":-4.296782,"eighty":-3.112056,"marketCap":92699920},{"date":"2025-12-12","current":-3.550733,"twenty":-5.86799,"median":-4.273096,"eighty":-3.162119,"marketCap":94370189},{"date":"2025-12-19","current":-3.582156,"twenty":-5.84457,"median":-4.262949,"eighty":-3.19281,"marketCap":95205323},{"date":"2025-12-26","current":-3.92117,"twenty":-5.843755,"median":-4.262949,"eighty":-3.21786,"marketCap":97093533},{"date":"2026-01-02","current":-3.424602,"twenty":-5.82283,"median":-4.235196,"eighty":-3.269261,"marketCap":84797846},{"date":"2026-01-09","current":-3.869801,"twenty":-5.792641,"median":-4.210604,"eighty":-3.333795,"marketCap":95821565},{"date":"2026-01-16","current":-3.698571,"twenty":-5.781725,"median":-4.16249,"eighty":-3.356755,"marketCap":91581673},{"date":"2026-01-23","current":-3.835555,"twenty":-5.769156,"median":-4.143012,"eighty":-3.358933,"marketCap":94973587},{"date":"2026-01-30","current":-3.921541,"twenty":-5.737734,"median":-4.109523,"eighty":-3.368971,"marketCap":97102724},{"date":"2026-02-06","current":-3.957191,"twenty":-5.706311,"median":-4.080473,"eighty":-3.382482,"marketCap":97985476},{"date":"2026-02-13","current":-4.206744,"twenty":-5.687458,"median":-4.063335,"eighty":-3.402348,"marketCap":104164740},{"date":"2026-02-20","current":-4.519036,"twenty":-5.682154,"median":-4.084915,"eighty":-3.42469,"marketCap":106812996},{"date":"2026-02-24","current":-4.257605,"twenty":-5.671547,"median":-4.099793,"eighty":-3.424867,"marketCap":100633732}],"updateTime":1772035839479},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTOR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586494473","title":"Citius Oncology Showcases LYMPHIR at American Society of Hematology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586494473","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586494473?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:01","pubTimestamp":1764075700,"startTime":"0","endTime":"0","summary":"Citius Oncology Inc. will exhibit at the 67th American Society of Hematology  Annual Meeting & Exposition, taking place December 6-9, 2025, in Orlando, Florida. The company will showcase its FDA-approved therapy, LYMPHIR, for the treatment of relapsed or refractory Stage I-III cutaneous T-cell lymphoma, at Booth #265. Company representatives will be available throughout the event to engage with physicians, researchers, and the oncology community.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citius Oncology Inc. published the original content used to generate this news brief via PR Newswire  on November 25, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL5HJn4M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","CTOR","CTXR"],"gpt_icon":0},{"id":"2585714636","title":"Citius Oncology to advance launch of Lymphir with Verix AI integration","url":"https://stock-news.laohu8.com/highlight/detail?id=2585714636","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585714636?lang=en_us&edition=fundamental","pubTime":"2025-11-21 21:45","pubTimestamp":1763732733,"startTime":"0","endTime":"0","summary":"Citius Oncology (CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals (CTXR), announced a deeper collaboration with Verix, a company in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citius-oncology-to-advance-launch-of-lymphir-with-verix-ai-integration-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citius-oncology-to-advance-launch-of-lymphir-with-verix-ai-integration-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTOR","BK4007","BK4139","CTXR"],"gpt_icon":0},{"id":"2576857470","title":"Citius Oncology Signs US Distribution Deal With McKesson for Lymphir","url":"https://stock-news.laohu8.com/highlight/detail?id=2576857470","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576857470?lang=en_us&edition=fundamental","pubTime":"2025-10-20 21:36","pubTimestamp":1760967405,"startTime":"0","endTime":"0","summary":"Citius Oncology  said Monday it has signed an agreement naming McKesson  as an authorized US distributor of Lymphir, an immunotherapy for adults with relapsed or refractory stage I to III cutaneous T-cell lymphoma.Financial details were not provided.McKesson joins two other distributors, completing the core US distribution network for Lymphir, Citius said.Lymphir has been approved by the US Food and Drug Administration, with a commercial launch planned for Q4, according to the company.Citius shares were up more than 5% in early trading Monday, and McKesson stock was slightly higher.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1023059063.AUD","BK4139","LU1037948897.HKD","LU1983260115.SGD","LU0861579265.USD","LU0314106906.USD","LU1057294990.SGD","LU0203347892.USD","LU0742534661.SGD","LU1430594728.SGD","MCK","CTOR","LU1814569148.SGD","LU2468319806.SGD","LU1366192091.USD","LU1934455194.USD","BK4585","BK4588","LU0942090050.USD","LU1037948541.HKD","LU0122379950.USD","LU1061106388.HKD","BK4175","LU0203345920.USD","LU1934455863.HKD","LU0868494708.USD","LU0251142724.SGD","LU2089984988.USD","BK4533","LU0965509101.SGD","LU2112291526.USD","LU0965509283.SGD","LU1934455277.USD","LU1506573853.SGD","LU0432979614.USD","LU0048573561.USD","LU0868494617.USD","LU2324357040.USD","LU0965509010.AUD","LU0251131958.USD","LU0965508806.USD","LU1585245621.USD"],"gpt_icon":0},{"id":"2576854147","title":"BRIEF-Citius Oncology Signs U.S. Distribution Agreement With Mckesson To Support Lymphir Commercial Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2576854147","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576854147?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:44","pubTimestamp":1760964285,"startTime":"0","endTime":"0","summary":"BRIEF-Citius Oncology Signs U.S. Distribution Agreement With Mckesson To Support Lymphir Commercial LaunchOct 20 (Reuters) - Citius Oncology Inc CTOR.O:CITIUS ONCOLOGY SIGNS U.S. DISTRIBUTION AGREEMEN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nTUA7N5VGC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0251131958.USD","LU0432979614.USD","LU1934455863.HKD","LU1934455194.USD","LU2324357040.USD","LU0048573561.USD","LU2089984988.USD","LU1037948897.HKD","MCK","LU1506573853.SGD","LU1023059063.AUD","LU0965508806.USD","LU1366192091.USD","BK4533","LU0942090050.USD","BK4007","LU0122379950.USD","LU0314106906.USD","LU0965509101.SGD","LU0868494708.USD","BK4585","LU0203345920.USD","BK4175","LU0965509010.AUD","CTXR","LU0965509283.SGD","LU0742534661.SGD","LU1934455277.USD","LU1983260115.SGD","LU1430594728.SGD","LU0861579265.USD","LU0203347892.USD","LU1037948541.HKD","LU1814569148.SGD","BK4139","CTOR","LU2468319806.SGD","BK4588","LU1057294990.SGD","LU2112291526.USD","LU1585245621.USD","LU0868494617.USD","LU0251142724.SGD","LU1061106388.HKD"],"gpt_icon":0},{"id":"2576915854","title":"Citius Oncology announces distribution agreement with McKesson","url":"https://stock-news.laohu8.com/highlight/detail?id=2576915854","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576915854?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:40","pubTimestamp":1760964010,"startTime":"0","endTime":"0","summary":"Citius Oncology (CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals (CTXR), announced it has entered into a distribution services agr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citius-oncology-announces-distribution-agreement-with-mckesson-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citius-oncology-announces-distribution-agreement-with-mckesson-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1585245621.USD","LU1934455277.USD","LU1366192091.USD","LU1023059063.AUD","LU0203345920.USD","CTOR","LU2468319806.SGD","LU1037948897.HKD","LU1934455194.USD","LU0965509010.AUD","BK4585","LU1814569148.SGD","LU0122379950.USD","LU2112291526.USD","LU0942090050.USD","LU1061106388.HKD","LU1430594728.SGD","LU0965509101.SGD","LU0965508806.USD","BK4139","LU0048573561.USD","CTXR","LU1983260115.SGD","LU0861579265.USD","LU0314106906.USD","BK4588","BK4007","LU0868494708.USD","BK4175","LU1934455863.HKD","LU2324357040.USD","LU0432979614.USD","MCK","LU0203347892.USD","LU0251142724.SGD","BK4533","LU1506573853.SGD","LU1037948541.HKD","LU2089984988.USD","LU0742534661.SGD","LU0868494617.USD","LU0965509283.SGD","LU1057294990.SGD","LU0251131958.USD"],"gpt_icon":0},{"id":"2575773744","title":"Citius Oncology Says Commercialization Deal Signed With Eversana for Planned Launch of Lymphir in Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2575773744","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575773744?lang=en_us&edition=fundamental","pubTime":"2025-10-16 21:36","pubTimestamp":1760621807,"startTime":"0","endTime":"0","summary":"Citius Pharmaceuticals'  oncology-focused unit Citius Oncology  said Thursday that it has signed an exclusive agreement with Eversana to support the planned US launch of the cutaneous T-cell lymphoma therapy Lymphir in Q4.Citius Oncology said Eversana will be its exclusive commercialization partner under the master services agreement, providing pre- and post-launch operations services such as medical information, revenue cycle management, and data and analytics.Shares of Citius Oncology were up 26% in recent trading on Thursday, while those of Citius Pharmaceuticals were up 34%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CTXR","CTOR","BK4007","BK4139"],"gpt_icon":0},{"id":"2575749696","title":"BRIEF-Citius Oncology Signs Exclusive Commercialization Agreement With EVERSANA To Support Planned Q4 2025 Launch Of LYMPHIR","url":"https://stock-news.laohu8.com/highlight/detail?id=2575749696","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575749696?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:49","pubTimestamp":1760618964,"startTime":"0","endTime":"0","summary":"BRIEF-Citius Oncology Signs Exclusive Commercialization Agreement With EVERSANA To Support Planned Q4 2025 Launch Of LYMPHIROct 16 (Reuters) - Citius Oncology Inc CTOR.O:CITIUS ONCOLOGY SIGNS EXCLUSIV","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA1XFCBY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","CTOR","BK4007","BK4139"],"gpt_icon":0},{"id":"2575674950","title":"Citius Oncology Inc: Co Plans to Commercially Launch Lymphir in United States in Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2575674950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575674950?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:47","pubTimestamp":1760618828,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA1XFCBY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","CTOR","CTXR"],"gpt_icon":0},{"id":"2575074950","title":"Citius Oncology Signs Exclusive Commercialization Agreement With Eversana to Support Planned Q4 2025 Launch of Lymphir™","url":"https://stock-news.laohu8.com/highlight/detail?id=2575074950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575074950?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:47","pubTimestamp":1760618828,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA1XFCBY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTXR","BK4007","CTOR","BK4139"],"gpt_icon":0},{"id":"2573966243","title":"Citius Sets Up Access to Lymphir in Southern Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2573966243","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573966243?lang=en_us&edition=fundamental","pubTime":"2025-10-07 23:04","pubTimestamp":1759849454,"startTime":"0","endTime":"0","summary":"Citius Oncology  said Tuesday it has entered into an exclusive distribution agreement with Greece-based Integris Pharma to make Lymphir available in Southern Europe.The partnership coverage includes Greece, Cyprus, Malta, Bulgaria, and Romania, it said. Lymphir is a targeted immune therapy for relapsed or refractory cutaneous T-cell lymphoma.The deal is part of its Named Patient Programs, also known as early access programs, Citius said, adding that it is in discussions with distribution partners to make the drug available through the program in Europe, South America and the Middle East.Price: 1.90, Change: +0.03, Percent Change: +1.66","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0912757837.SGD","LU1621768115.EUR","CTOR","IE00B29SXK94.USD","LU1718418525.SGD","LU0310799852.SGD","BK4139","IE00B29SXL02.USD","SO","LU2133065610.SGD","LU1732800096.USD","IE00BMG7P819.SGD","LU0211327993.USD","BK4585","LU0795875169.SGD","LU0070217475.USD","BK4588","BK4081","LU0098860793.USD","LU1267930490.SGD","IE00BMG7P694.USD","LU1621767810.EUR","LU1929549753.HKD","LU0211328371.USD","IE00BMG7P926.USD","LU1621767737.EUR","LU1621768206.USD","LU0795875086.SGD","LU1732799900.SGD","LU2384288077.EUR","LU2347655156.SGD","LU0320765646.SGD","LU2347655073.USD","IE00BMG7P587.USD","LU0726765562.USD","LU1162221912.USD"],"gpt_icon":0},{"id":"2573192950","title":"BRIEF-Citius Oncology Enters Exclusive Distribution Agreement With Integris Pharma S.A.","url":"https://stock-news.laohu8.com/highlight/detail?id=2573192950","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573192950?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:52","pubTimestamp":1759841555,"startTime":"0","endTime":"0","summary":"BRIEF-Citius Oncology Enters Exclusive Distribution Agreement With Integris Pharma S.A.Oct 7 (Reuters) - Citius Oncology Inc CTOR.O:CITIUS ONCOLOGY INC - ENTERS EXCLUSIVE DISTRIBUTION AGREEMENT WITH I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO026:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2573295098","title":"Citius Oncology Inc - Enters Exclusive Distribution Agreement With Integris Pharma S.a.","url":"https://stock-news.laohu8.com/highlight/detail?id=2573295098","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573295098?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:48","pubTimestamp":1759841334,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO026:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CTOR"],"gpt_icon":0},{"id":"2569654797","title":"Citius Oncology Raised to Buy From Hold by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2569654797","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569654797?lang=en_us&edition=fundamental","pubTime":"2025-09-23 19:57","pubTimestamp":1758628620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTOR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 23, 2025 07:57 ET (11:57 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2569920427","title":"Citius Oncology  upgraded to Buy from Hold at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2569920427","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569920427?lang=en_us&edition=fundamental","pubTime":"2025-09-23 19:30","pubTimestamp":1758627017,"startTime":"0","endTime":"0","summary":"Maxim analyst Michael Okunewitch upgraded Citius Oncology (CTOR) to Buy from Hold with a $6 price target Published first on TheFly – the ultimate s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citius-oncology-upgraded-to-buy-from-hold-at-maxim-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citius-oncology-upgraded-to-buy-from-hold-at-maxim-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2569792629","title":"Citius Oncology Inc : Maxim Group Raises to Buy From Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2569792629","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569792629?lang=en_us&edition=fundamental","pubTime":"2025-09-23 19:27","pubTimestamp":1758626874,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nFWN3VA0KH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2566982490","title":"BRIEF-Citius Oncology Announces Closing Of $9 Million Registered Direct Offering And Concurrent Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2566982490","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566982490?lang=en_us&edition=fundamental","pubTime":"2025-09-11 04:34","pubTimestamp":1757536476,"startTime":"0","endTime":"0","summary":"BRIEF-Citius Oncology Announces Closing Of $9 Million Registered Direct Offering And Concurrent Private PlacementSept 10 (Reuters) - Citius Oncology Inc CTOR.O:CITIUS ONCOLOGY ANNOUNCES CLOSING OF $9.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nTUABKV5FY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","BK4007","CTOR","BK4139"],"gpt_icon":0},{"id":"2566738690","title":"Citius Oncology Prices $9 Million Securities Offering, Concurrent Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2566738690","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566738690?lang=en_us&edition=fundamental","pubTime":"2025-09-09 21:14","pubTimestamp":1757423669,"startTime":"0","endTime":"0","summary":"Citius Oncology  said Tuesday it expects to raise $9 million in gross proceeds from a registered direct offering and concurrent private placement.The company said it has signed an agreement to sell about 5.1 million common shares to an institutional investor at $1.75 apiece.Citius Oncology has also agreed to issue warrants to buy up to roughly 5.1 million common shares, it said, adding that the warrants can be exercised at $1.84 per share.The offering will likely be completed around Wednesday, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2566697542","title":"BRIEF-Citius Oncology Prices $9M Direct Offering & Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2566697542","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566697542?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:37","pubTimestamp":1757421421,"startTime":"0","endTime":"0","summary":"BRIEF-Citius Oncology Prices $9M Direct Offering & Private PlacementSept 9 (Reuters) - Citius Oncology Inc CTOR.O:CITIUS ONCOLOGY ANNOUNCES PRICING OF $9.0 MILLION REGISTERED DIRECT OFFERING AND CONCU","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUA5NXBFP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CTXR","CTOR","BK4007"],"gpt_icon":0},{"id":"2566802697","title":"Citius Oncology Inc - Offering Price for Share and Warrant Is $1.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2566802697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566802697?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:30","pubTimestamp":1757421004,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUA5NXBFP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTXR","BK4139","CTOR","BK4007"],"gpt_icon":0},{"id":"2566697392","title":"Press Release: Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2566697392","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566697392?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:30","pubTimestamp":1757421000,"startTime":"0","endTime":"0","summary":"CRANFORD, N.J., Sept. 9, 2025 /PRNewswire/ -- Citius Oncology, Inc.  , the oncology-focused subsidiary of Citius Pharmaceuticals, Inc.  , a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 5,142,858 shares of common stock in a registered direct offering. In a concurrent private placement, the Company also agreed to issue unregistered warrants to purchase up to an aggregate of 5,142,858 shares of common stock. The combined effective offering price for each share of common stock and accompanying warrant is $1.75. The warrants will have an exercise price of $1.84 per share, will be exercisable six months from the date of issuance, and will expire on the five and one-half year anniversary from the date of issuance.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","BK4139","R","NQmain","CTXR","BK4232","BK4007","BK4022"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":41,"code":"91000000","status":"200"}]}}